Literature DB >> 26972852

Non-clear-cell renal carcinoma therapy: handle with care.

Sebastiano Buti1, Melissa Bersanelli2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26972852     DOI： 10.1016/S1470-2045(16)00013-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

Review 1.  Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy.

Authors:  Sebastiano Buti; Alessandro Leonetti; Alice Dallatomasina; Melissa Bersanelli
Journal:  Core Evid       Date:  2016-09-01

Review 2.  Pazopanib as a possible option for the treatment of metastatic non-clear cell renal carcinoma patients: a systematic review.

Authors:  Melissa Bersanelli; Matteo Brunelli; Letizia Gnetti; Umberto Maestroni; Sebastiano Buti
Journal:  Ther Adv Med Oncol       Date:  2020-05-26       Impact factor: 8.168
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.